STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)
$54.51 -0.63 (-1.1425%)
Analysed STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) News Sources
Assessing Structure Therapeutics (GPCR) Valuation After Recent Share Price Weakness
09-04-2026
yahoo.com
Guggenheim Remains Bullish on Eli Lilly (LLY) Ahead of Q1 2026 Results
08-04-2026
yahoo.com
How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval
06-04-2026
yahoo.com
LLY Stock Up on GLP-1 Pill Approval: Can it Outpace NVO's Wegovy Pill?
02-04-2026
yahoo.com
These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
01-04-2026
247wallst.com
Structure Therapeutics Phase 2 Obesity Data Shifts Focus To Phase 3
29-03-2026
yahoo.com
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
23-03-2026
yahoo.com
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
22-03-2026
fool.com
Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug
19-03-2026
yahoo.com
Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?
18-03-2026
yahoo.com
What is the current price of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)?
The current price of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) is $54.51.
STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) since the previous trading day is $-0.63.
STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) since the previous trading day is -1.1425%.
What is the most recent average sentiment score for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)?
The most recent average sentiment score for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)?
The most recent sentiment for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) is .
SEC-8K** Filing Available For STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.